₹79.71
-0.79 (-0.98%)
As of 27 Aug 2026, Concord Drugs Ltd share price is ₹79.71. The stock opened at ₹79.71 and had closed at ₹80.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹56.00 and a high of ₹92.52. In terms of performance, Concord Drugs Ltd share price has increased by 4.71% over the past six months and has increased by 36.16% over the last year.
Concord Drugs Charts
Concord Drugs Ltd Overview
Market cap₹106 Crs
Volume3,894
Prev. Close₹80.50
Year range₹56.00 - ₹92.52
Total Value₹3,10,390.74
ISININE858L01010
About Concord Drugs
Concord Drugs is to manufacture licensed drugs based on the formulations approved.
Concord Drugs Ltd Historical Performance
1 Month Return18.50%
6 Month Return3.13%
3 Year Return123.92%
3 Month Return-1.57%
1 Year Return42.96%
5 Year Return193.26%
Concord Drugs Ltd Fundamental Analysis
ROCE(TTM)4.82%
P/E Ratio (TTM)51.94
P/B Ratio2.19
Debt to Equity0.24
ROE2.14%
EPS (TTM)1.55
Dividend Yield0.00%
Book Value36.82
Profit Margin2.45%
Operating Margin5.05%
Concord Drugs Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 20.90 | 35.56 | 16.86 | 10.07 | 13.38 |
| EBITDA | 2.24 | 1.42 | 0.89 | 1.01 | 0.94 |
| Net Profit | 1.11 | 0.52 | 0.22 | 0.19 | 0.11 |
| EPS | 0.84 | 0.46 | 0.16 | 0.19 | 0.11 |
Concord Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 64.91 |
| MACD | 1.14 |
| 20-Day SMA | 73.39 |
Concord Drugs Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Concord Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Concord Drugs Ltd today is ₹79.71 on NSE and ₹79.71 on BSE.
- The 52-week high of Concord Drugs Ltd is ₹92.52, while the 52-week low is ₹56.00.
- The current market capitalisation of Concord Drugs Ltd is approximately ₹106 crore.
- The P/E (Price-to-Earnings) ratio of Concord Drugs Ltd is 126.33. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Concord Drugs Ltd is 2.09. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Concord Drugs Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Concord Drugs Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Concord Drugs Ltd has delivered a return of approximately 123.92%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Concord Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 45.08% promoters, 0.00% FIIs, 0.00% DIIs, and 54.19% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
